ArticleBMJ open2024

Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trials.

Zoe McQuilten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.